Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Dr. Antoni Ribas Discusses New Combination Therapy to Treat Metastatic Melanoma

POSTED: Oct. 5, 2012 Share

In this 13-minute interview, Dr. Antoni Ribas of UCLA's Jonsson Comprehensive Cancer Center provides an extesnive overview of the latest positive advancements in the use of combined BRAF and MEK inhibitors to treat metastic melanoma. These latest findings provide strong support for testing the combination therapy in future human clinical trials, which Jonsson Cancer Center researchers hope to launch within two years.

Last updated: 1/22/2013 12:05:48 PM